BioCentury
ARTICLE | Strategy

Premium, but not Top Shelf

December 10, 2001 8:00 AM UTC

While Aviron (AVIR) and (CORR) are getting taken out at premiums, neither company is selling out at its peak. Millennium's Friday close of $28.41 values CORR at $1.65 billion, just under half its $3.4...